AS
RGNX icon

Altshuler Shaham’s Regenxbio RGNX Stock Holding History

Altshuler Shaham’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,072
Closed -$229K – 531
2020
Q1 		$229K Sell
7,072
-2,589
-27% -$108K 0.01% 119
2019
Q4 		$396K Hold
9,661
– – 0.01% 111
2019
Q3 		$332K Buy
9,661
+209
+2% +$8.47K 0.01% 98
2019
Q2 		$486K Buy
9,452
+888
+10% +$44.3K 0.02% 100
2019
Q1 		$491K Hold
8,564
– – 0.02% 101
2018
Q4 		$359K Sell
8,564
-6,225
-42% -$365K 0.02% 105
2018
Q3 		$1.12M Hold
14,789
– – 0.06% 83
2018
Q2 		$1.06M Sell
14,789
-8,000
-35% -$382K 0.09% 82
2018
Q1 		$680K Sell
22,789
-411
-2% -$12K 0.09% 88
2017
Q4 		$771K Buy
+23,200
New +$699K 0.11% 67

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altshuler Shaham's RGNX Position: Q2 2020 in Review

Altshuler Shaham sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 7,072 shares — an estimated $229K sold.

Altshuler Shaham first reported a position in RGNX in Q4 2017 and held it in 10 quarters. The position peaked at $1.12M in Q3 2018. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

  • Altshuler Shaham reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
  • Altshuler Shaham sold 7,072 Regenxbio shares in Q2 2020, an estimated $229K.
  • Altshuler Shaham first reported a position in Regenxbio in Q4 2017 and held it in 10 quarters.
  • Altshuler Shaham's Regenxbio position peaked at $1.12M in Q3 2018.
  • 179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Altshuler Shaham's 13F filing for Q2 2020, filed 13 Aug 2020.